However, targeting several other RTKs including the epidermal growth factor receptor (EGFR) and the insulin-like growth factor receptor (IGF1R) in breast tumors has been mostly unsuccessful (4, 7, 8). The gene discussed is IGF1R; the disease is breast neoplasm.